The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery
Abstract
Self-assembling polycation/DNA complexes represent a promising synthetic vector for gene delivery. However, despite considerable versatility and transfectional activity in vitro, such materials are quickly eliminated from the bloodstream following intravenous injection (plasma alpha half-life typically less than 5 min). For targeted systemic delivery a more prolonged plasma circulation of the vector is essential. Here we have examined factors contributing to rapid elimination of poly(L-lysine) (pLL)/DNA complexes from the bloodstream, and implicate the binding of proteins to the polyelectrolyte complexes as a likely cause for their blood clearance. pLL/DNA complexes reisolated from serum associate with several proteins, depending on their net charge, although the major band on SDS-PAGE co-migrates with albumin. Serum albumin binds to pLL/DNA complexes in vitro, forming a ternary pLL/DNA/albumin complex which regains some ethidium bromide fluorescence and fails to move during agarose electrophoresis. Albumin also causes increased turbidity of complexes, and reduces their zeta potential to the same level (-16 mV) as is measured in serum. We propose that rapid plasma elimination of polycation/DNA complexes results from their binding serum albumin and other proteins, perhaps due to aggregation and phagocytic capture or accumulation of the ternary complexes in fine capillary beds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, cationic non-viral vectors used to condense negatively charged CRISPR RNPs and plasmids are prone to interact with plasma proteins and the physiological salt in physiological conditions, resulting in the recognition and clearance by the reticuloendothelial system (RES) [141–143].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [142]
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Plank, C., Mechtler, K., Szoka, F. C., & Wagner, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1437 · Cited by 584
In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes
Li, S., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300482 · Cited by 478
Kawabata, K., Takakura, Y., & Hashida, M. (1995) · Pharmaceutical Research · doi:10.1023/a:1016248701505 · Cited by 460
Wolfert, M. A., Schacht, E. H., Toncheva, V. D., Ulbrich, K., Nazarova, O. V., & Seymour, L. W. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2123 · Cited by 365
Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold.
Boussif, O., Zanta, M. A., & Behr, J. (1996) · PubMed · Cited by 345
Passive tumor targeting of soluble macromolecules and drug conjugates.
Seymour, L. W. (1992) · PubMed · Cited by 316
Influence of Cholesterol on the Association of Plasma Proteins with Liposomes
Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochemistry · doi:10.1021/bi950414i · Cited by 291
Liu, F., Qi, H., Huang, L., & Liu, D. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300424 · Cited by 247
Takakura, Y., & Hashida, M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016084508097 · Cited by 226
Research works printed but not linked: 4
- Velu T . Gene transfer and therapy in Europe: research, development and clinical trials Publication of the European Union: Brussels 1996
- Graham RW . Encapsulated transmembrane carrier systems for gene therapy Proceedings of the Keystone Symposium on Synthetic Non-viral Gene Delivery Systems 1998 135: (Abstr. 212)
- Ward CM, Seymour LW . A novel assay for determination of polycation concentration using turbidometry J Bioact Compat Polym 1998 (in press)
- Semple SC, Chonn A, Cullis PR . Influence of cholesterol on the association of plasma proteins with liposomes Biochemistry 1996 35: 2521–2525 · DOI
Cited by
Sorted by citations
Design and development of polymers for gene delivery
Pack, D. W., Hoffman, A. S., Pun, S., & Stayton, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1775 · Cited by 2,568
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Singh, R. N., Pantarotto, D., Lacerda, L., Pastorin, G., Klumpp, C., Prato, M., Bianco, A., & Kostarelos, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509009103 · Cited by 1,042
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 970
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 880
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 790
Protein Interactions with Polymer Coatings and Biomaterials
Wei, Q., Becherer, T., Angioletti‐Uberti, S., Dzubiella, J., Wischke, C., Neffe, A. T., Lendlein, A., Ballauff, M., & Haag, R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400546 · Cited by 754
Different behavior of branched and linear polyethylenimine for gene deliveryin vitro andin vivo
Wightman, L., Kircheis, R., R�ssler, V., Carotta, S., Ruzicka, R., Kursa, M., & Wagner, E. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.187 · Cited by 702
An overview of current delivery systems in cancer gene therapy
El‐Aneed, A. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.013 · Cited by 694
Design and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 661
Gene delivery by lipoplexes and polyplexes
de Ilarduya, C. T., Sun, Y., & Düzgüneş, N. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.019 · Cited by 626
Cationic lipids, lipoplexes and intracellular delivery of genes
Wasungu, L., & Hoekstra, D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.024 · Cited by 616
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00343-6 · Cited by 454
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415
Characterization of folate-chitosan-DNA nanoparticles for gene therapy
Mansouri, S., Yan, C., Winnik, F. M., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, É., & Fernandes, J. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.09.020 · Cited by 389
Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications
Shim, M. S., & Kwon, Y. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.018 · Cited by 389
Development of Biomaterials for Gene Therapy
Han, S.-O., Mahato, R. I., Sung, Y. K., & Kim, S. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0142 · Cited by 388
Gene delivery with synthetic (non viral) carriers
Brown, M. D., Schätzlein, A. G., & Uchegbu, I. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00861-4 · Cited by 365
Polymeric Delivery of Therapeutic Nucleic Acids
Kumar, R., Chalarca, C. F. S., Bockman, M. R., Bruggen, C. V., Grimme, C. J., Dalal, R. J., Hanson, M. G., Hexum, J. K., & Reineke, T. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00997 · Cited by 379
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 374
Kneuer, C., Sameti, M., Bakowsky, U., Schiestel, T., Schirra, H., Schmidt, H. K., & Lehr, C. (2000) · Bioconjugate Chemistry · doi:10.1021/bc0000637 · Cited by 360
Recent Advances in Nanomaterials for Gene Delivery—A Review
Riley, M., & Vermerris, W. (2017) · Nanomaterials · doi:10.3390/nano7050094 · Cited by 373
Kircheis, R., Wightman, L., Schreiber, A. D., Robitza, B., Roessler, V., Kursa, M., & Wagner, E. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301351 · Cited by 350
Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector
Chen, B., Liu, M., Zhang, L., Huang, J., Yao, J., & Zhang, Z. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm10341e · Cited by 341
Taratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 326
Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Zou, S., Erbacher, P., Rémy, J.-S., & Behr, J. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200003/04)2:2 · Cited by 317
Nelson, C. E., Kintzing, J. R., Hanna, A., Shannon, J. M., Gupta, M. K., & Duvall, C. L. (2013) · ACS Nano · doi:10.1021/nn403325f · Cited by 296
Gene Therapies for Cancer: Strategies, Challenges and Successes
Das, S. K., Menezes, M. E., Bhatia, S., Wang, X., Emdad, L., Sarkar, D., & Fisher, P. B. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24791 · Cited by 298
Oupický, D., Ogris, M., Howard, K. A., Dash, P. R., Ulbrich, K., & Seymour, L. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0568 · Cited by 286
Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupický, D., Barrett, L. B., Spice, R., Kendall, M. A. F., Berry, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni085 · Cited by 279
Kakizawa, Y., Harada, A., & Kataoka, K. (2001) · Biomacromolecules · doi:10.1021/bm000142l · Cited by 256
Molecular design of functional polymers for gene therapy
Jeong, J. H., Kim, S. W., & Park, T. G. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.019 · Cited by 256
Stability of PEI–DNA and DOTAP–DNA complexes: effect of alkaline pH, heparin and serum
Moret, I., Peris, J., Guillem, V. M., Benet, M., Revert, F., Dası́, F., Crespo, A., & Aliño, S. F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00415-1 · Cited by 237
Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers
Park, M. R., Han, K. O., Han, I. K., Cho, M., Nah, J. W., Choi, Y. J., & Cho, C. S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.008 · Cited by 236
Ogris, M., Carlisle, R. C., Bettinger, T., & Seymour, L. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108331200 · Cited by 226
Lin, S. B., Du, F., Wang, Y., Ji, S., Liang, D., Yu, L. M., & Li, Z. (2007) · Biomacromolecules · doi:10.1021/bm7008747 · Cited by 227
Extracellular Barriers to in Vivo PEI and PEGylated PEI Polyplex-Mediated Gene Delivery to the Liver
Burke, R. S., & Pun, S. H. (2008) · Bioconjugate Chemistry · doi:10.1021/bc700388u · Cited by 222
Recent progress in gene delivery using non-viral transfer complexes
Godbey, W. T., & Mikos, A. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00267-x · Cited by 218
Ignatovich, I. A., Dizhe, E. B., Pavlotskaya, A. V., Akifiev, B. N., Burov, S. V., Orlov, S., & Ap, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301431200 · Cited by 205
Eliyahu, H., Barenholz, Y., & Domb, A. J. (2005) · Molecules · doi:10.3390/10010034 · Cited by 209
Polyethylenimines for siRNA and miRNA delivery in vivo
Höbel, S., & Aigner, A. M. (2013) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1228 · Cited by 210
Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier
Park, I., Kim, T. H., Park, Y. H., Shin, B. A., Choi, E. S., Chowdhury, E. H., Akaike, T., & Cho, C. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00448-5 · Cited by 203
Ward, C. M., Read, M. L., & Seymour, L. W. (2001) · Blood · doi:10.1182/blood.v97.8.2221 · Cited by 191
Non-viral vectors in cancer gene therapy: principles and progress
Schätzlein, A. G. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00001 · Cited by 187
Polymer gene delivery: overcoming the obstacles
Aied, A., Greiser, U., Pandit, A. S., & Wang, W. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.06.014 · Cited by 174
Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions
Ballarín-González, B., & Howard, K. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.004 · Cited by 164
Trubetskoy, V. S., Wong, S. C., Subbotin, V. M., Budker, V. G., Loomis, A., Hagstrom, J. E., & Wolff, J. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301888 · Cited by 164
Dash, P. R., Read, M. L., Fisher, K., Howard, K. A., Wolfert, M. A., Oupický, D., Šubr, V., Strohalm, J., Ulbrich, K., & Seymour, L. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3793 · Cited by 161
Poddar, A., Conesa, J. J., Liang, K., Dhakal, S., Reineck, P., Bryant, G., Pereiro, E., Riccò, R., Amenitsch, H. W., Doonan, C. J., et al. (2019) · Small · doi:10.1002/smll.201902268 · Cited by 162
Targeting tumors with non-viral gene delivery systems
Ogris, M., & Wagner, E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02243-2 · Cited by 158
Strategies to overcome the polycation dilemma in drug delivery
Bernkop‐Schnürch, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.017 · Cited by 155
Yuan, P., Hu, Q., Tang, G., & Li, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.071 · Cited by 156
Polymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 158
Progress and perspectives in developing polymeric vectors for in vitro gene delivery
Yue, Y., & Wu, C. C. (2012) · Biomaterials Science · doi:10.1039/c2bm00030j · Cited by 158
Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy
Minigo, G., Scholzen, A., Tang, C. K., Hanley, J. C., Kalkanidis, M., Pietersz, G. A., Apostolopoulos, V., & Plebanski, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.086 · Cited by 151
Verbaan, F. J., Oussoren, C., Snel, C. J., Crommelin, D. J. A., Hennink, W. E., & Storm, G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.475 · Cited by 150
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Hartig, S. M., Greene, R. R., Dikov, M. M., Prokop, A., & Davidson, J. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9459-1 · Cited by 150
Finsinger, D., Remy, J.-S., Erbacher, P., Koch, C., & Plank, C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301227 · Cited by 148
Functional lipids and lipoplexes for improved gene delivery
Zhang, X., McIntosh, T. J., & Grinstaff, M. W. (2011) · Biochimie · doi:10.1016/j.biochi.2011.05.005 · Cited by 148
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
Miteva, M., Kirkbride, K. C., Kilchrist, K. V., Werfel, T. A., Li, H., Nelson, C. E., Gupta, M. K., Giorgio, T. D., & Duvall, C. L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.036 · Cited by 140
Tissue-specific gene delivery via nanoparticle coating
Harris, T. J., Green, J. J., Fung, P. W., Langer, R., Anderson, D. G., & Bhatia, S. N. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.012 · Cited by 138
Polyion complex (PIC) particles: Preparation and biomedical applications
Insua, I., Wilkinson, A., & Fernández‐Trillo, F. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.06.003 · Cited by 143
Proteins and polyelectrolytes: A charged relationship
Becker, A. L., Henzler, K. D., Welsch, N., Ballauff, M., & Borisov, O. V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2011.10.001 · Cited by 136
Poly-l-glutamic acid derivatives as vectors for gene therapy
Dekie, L., Toncheva, V., Dubruel, P., Schacht, E. H., Barrett, L. B., & Seymour, L. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00235-7 · Cited by 134
Supramolecular assemblies in functional siRNA delivery: Where do we stand?
Aliabadi, H. M., Landry, B. K., Sun, C., Tang, T., & Uludağ, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.079 · Cited by 135
Cationic nanoparticles for cancer therapy
Bilensoy, E. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.485983 · Cited by 123
Wetting Properties of Bile Salt Solutions and Dissolution Media
Luner, P. E. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200003)89:3 · Cited by 29
Polyhistidine–PEG:DNA nanocomposites for gene delivery
Putnam, D. A., Zelikin, A. N., Izumrudov, V. A., & Langer, R. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00341-7 · Cited by 121
Neu, M., Germershaus, O., Béhé, M. P., & Kissel, T. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.009 · Cited by 121
Materials for Non-Viral Gene Delivery
Segura, T., & Shea, L. D. (2001) · Annual Review of Materials Research · doi:10.1146/annurev.matsci.31.1.25 · Cited by 120
Wakebayashi, D., Nishiyama, N., Yamasaki, Y., Itaka, K., Kanayama, N., Harada, A., Nagasaki, Y., & Kataoka, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.003 · Cited by 119
Pezzoli, D., Giupponi, E., Mantovani, D., & Candiani, G. (2017) · Scientific Reports · doi:10.1038/srep44134 · Cited by 121
Gary, D. J., Lee, H., Sharma, R., Lee, J., Kim, Y.-W., Cui, Z., Jia, D., Bowman, V. D., Chipman, P. R., Wan, L., et al. (2011) · ACS Nano · doi:10.1021/nn102540y · Cited by 117
Bertschinger, M., Backliwal, G., Schertenleib, A., Jordan, M., Hacker, D. L., & Wurm, F. M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.006 · Cited by 115
DEWOLF, H., Snel, C. J., Verbaan, F. J., Schiffelers, R. M., Hennink, W. E., & Storm, G. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.029 · Cited by 112
How to screen non-viral gene delivery systems in vitro?
van Gaal, E. V. B., van Eijk, R., Oosting, R. S., Kok, R. J., Hennink, W. E., Crommelin, D. J. A., & Mastrobattista, E. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.001 · Cited by 110
York, A. W., Zhang, Y., Holley, A. C., Guo, Y., Huang, F., & McCormick, C. L. (2009) · Biomacromolecules · doi:10.1021/bm8014768 · Cited by 110
Fisher, K. D., Ulbrich, K., Šubr, V., Ward, C. M., Mautner, V., Blakey, D. C., & Seymour, L. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301230 · Cited by 112
Díaz‐Moscoso, A., Gourriérec, L. L., Gómez-Garcı́a, M., Benito, J. M., Balbuena, P., Ortega‐Caballero, F., Guilloteau, N., Giorgio, C. D., Vierling, P., Defaye, J., et al. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200901149 · Cited by 112
Adsorption of proteins to functional polymeric nanoparticles
Welsch, N., Lu, Y. Q., Dzubiella, J., & Ballauff, M. (2013) · Polymer · doi:10.1016/j.polymer.2013.03.027 · Cited by 107
DNA condensation induced by metal complexes
Li, G., Guan, R., Ji, L., & Chao, H. (2014) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.09.005 · Cited by 108
Wang, Y., Shahi, P. K., Wang, X., Xie, R., Zhao, Y., Wu, M., Roge, S., Pattnaik, B. R., & Gong, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.030 · Cited by 104
Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life
Sato, A., Choi, S. W., Hirai, M., Yamayoshi, A., Moriyama, R., Yamano, T., Takagi, M., Kano, A., Shimamoto, A., & Maruyama, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.018 · Cited by 103
Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
Wilson, K. D., de Jong, S. D., & Tam, Y. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.014 · Cited by 101
Ward, C. M., Pechar, M., Oupický, D., Ulbrich, K., & Seymour, L. W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.296 · Cited by 100
Akagi, D., Oba, M., Koyama, H., Nishiyama, N., Fukushima, S., Miyata, T., Nagawa, H., & Kataoka, K. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302945 · Cited by 100
A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy
Park, J. Y., Singha, K., Son, S., Kim, J., Namgung, R., Yun, C.-O., & Kim, W.-J. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.64 · Cited by 100
Phosphonium-Containing Polyelectrolytes for Nonviral Gene Delivery
Hemp, S. T., Allen, M. H., Green, M., & Long, T. E. (2011) · Biomacromolecules · doi:10.1021/bm201503a · Cited by 100
Therapeutic targeting in the silent era: advances in non-viral siRNA delivery
Guo, J., Fisher, K. A., Darcy, R., Cryan, J. F., & O’Driscoll, C. M. (2010) · Molecular BioSystems · doi:10.1039/c001050m · Cited by 100
PEI-alginate nanocomposites as efficient in vitro gene transfection agents
Patnaik, S., Aggarwal, A., Nimesh, S., Goel, A., Ganguli, M., Saini, N., Singh, Y. P., & Gupta, K. C. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.025 · Cited by 94
Fischer, D., Osburg, B., Petersen, H., Kissel, T., & Bickel, U. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02982-9 · Cited by 94
Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery
Qi, R., Liu, S., Chen, J., Xiao, H., Yan, L., Huang, Y., & Jing, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.015 · Cited by 93
Optimization and delivery of plasmid DNA for vaccination
Jechlinger, W. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.6.803 · Cited by 92
IONP‐PLL: a novel non‐viral vector for efficient gene delivery
Xiang, J., Tang, J., Zhu, S., Nie, X., Lu, H., Shen, S., Li, X., Tang, K., Zhou, M., & Li, G. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.419 · Cited by 93
Luo, X., Huang, F., Qin, S., Wang, H.-F., Feng, J., Zhang, X., & Zhuo, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.011 · Cited by 90
pH‐Responsive Polymers as Gene Carriers
Park, I., Singha, K., Arote, R. B., Choi, Y., Kim, W. J., & Cho, C. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.200900867 · Cited by 91
Synthesis of Stable Multifunctional Perfluorocarbon Nanoemulsions for Cancer Therapy and Imaging
Fernandes, D. A., Fernandes, D. D., Li, Y., Wang, Y., Zhang, Z., Rousseau, D., Gradinaru, C. C., & Kolios, M. C. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b01867 · Cited by 88
Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides
White, P. J., Anastasopoulos, F., Pouton, C. W., & Boyd, B. J. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001021 · Cited by 87
Metadata
- Authors
- Dash, P. R., Read, M. L., Barrett, L. B., Wolfert, M. A., & Seymour, L. W.
- Affiliations
- University of Birmingham (GB)
- Venue
- Gene Therapy
- Published
- 1999-04-01
- Volume
- 6
- Issue
- 4
- Pages
- 643-650
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2031185644
- Cited by
- 386
- References
- 24
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 7 · 2022: 3 · 2021: 5 · 2020: 9 · 2019: 14 · 2018: 11 · 2017: 13 · 2016: 14 · 2015: 11 · 2014: 22 · 2013: 31 · 2012: 22
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- British Heart Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polyelectrolyte complexes, gene delivery, poly-L-lysine, DNA, blood clearance, serum albumin, protein binding, plasma half-life, zeta potential, complex aggregation, phagocytosis, intravenous injection, systemic drug delivery
- MeSH terms
- Albumins, Animals, DNA, Electrophoresis, Agar Gel, Female, Genetic Vectors, Metabolic Clearance Rate, Mice, Inbred BALB C, Polylysine, Protein Binding, Transfection, Genetic Therapy, Treatment Failure, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review